Politician trade (House)

Medtronic (MDT): Rep. Julie Johnson (TX32) disclosed a partial sale $1K–$15K

Rep. Julie Johnson (TX32) disclosed a partial sale of Medtronic in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
28 days
Disclosure lag
Traded
Aug 14, 2025
Disclosed
Sep 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. May 8, 2025CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  3. Aug 14, 2025 · this disclosureCongressDisclosed partial sale of MDT — reported range $1,001 - $15,000

What came next

  1. Aug 22, 2025InsiderDirector purchased ~$232K of MDT shares in the open market
  2. Aug 25, 2025InsiderDirector purchased ~$231K of MDT shares in the open market
  3. Sep 3, 2025Insider · 1 personInsiders: 2 sales (~$788K)
  4. Sep 29, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  5. Oct 16, 2025Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  6. Oct 17, 2025FDAFDA device clearance: StealthStation S8 Spine Software
  7. Oct 20, 2025FDARecall: Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03
  8. Oct 21, 2025FDARecall: CareLink Clinic, REF: MMT-7350
  9. Oct 24, 2025FDAFDA device clearance: Parietene™ Flat Sheet Mesh
  10. Oct 24, 2025FDAFDA device clearance: Infinity™ OCT System
  11. Oct 24, 2025FDAFDA device clearance: CD Horizon™ Spinal System
  12. Oct 29, 2025FDAFDA device clearance: Telescope Guide Extension Catheter
  13. Oct 29, 2025FDARecall: Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable cardioverter defibrillators (ICD), Product Number DVEA3E4
  14. Nov 1, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 1, 2025, Gregory L. Smith, Executive Vice President, Enterprise Operations of Medtronic plc (the Company), notified the Company of his decision to retire from the Company, effective December 2, 2025, and to join a private equity-held organization.”
  15. Nov 2, 2025FDARecall: MiniMed 780G Insulin Pump Catalog Numbers: MMT-1884 MMT-1886 With Software Version 6.60 The MiniMed 780G insulin pump is indicated for use by patients age 7-80…
  16. Nov 5, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  17. Nov 13, 2025FDARecall: InPen App, Model/CFN Number: MMT-8061 (Android Users)
  18. Nov 13, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  19. Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
  20. Nov 19, 2025Insider · 1 personInsiders: 7 sales (~$3.1M)
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Rep. Julie Johnson (TX32)

The full history of Rep. Julie Johnson (TX32) is on the profile page.

How this filing works

Explore the data

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data